Top compounds associated with response to LYRM5


Feature Type Standardized
Nominal ANOVA
mRNA BRD-A94377914 CTRPv2 pan-cancer AAC -0.086 0.04
mRNA GSK2636771 CTRPv2 pan-cancer AAC -0.086 0.04
mRNA CD-437 CTRPv2 pan-cancer AAC -0.085 0.007
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.084 0.03
mRNA Irinotecan gCSI pan-cancer AAC -0.083 0.1
mRNA BRD-K61166597 CTRPv2 pan-cancer AAC -0.081 0.01
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.08 0.04
mRNA Camptothecin GDSC1000 pan-cancer AAC -0.08 0.01
mRNA ibrutinib CTRPv2 pan-cancer AAC -0.08 0.05
mRNA CBB-1007 CTRPv2 pan-cancer AAC -0.08 0.1
Download CSV